Blair William & Co. IL Has $9.15 Million Stock Position in McKesson Corporation $MCK

Blair William & Co. IL lowered its stake in McKesson Corporation (NYSE:MCK - Free Report) by 6.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,492 shares of the company's stock after selling 827 shares during the quarter. Blair William & Co. IL's holdings in McKesson were worth $9,154,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of McKesson by 1.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 863 shares of the company's stock valued at $632,000 after buying an additional 14 shares during the period. CVA Family Office LLC increased its stake in shares of McKesson by 6.0% in the first quarter. CVA Family Office LLC now owns 265 shares of the company's stock valued at $178,000 after buying an additional 15 shares during the period. Palisade Asset Management LLC raised its stake in shares of McKesson by 2.1% during the first quarter. Palisade Asset Management LLC now owns 715 shares of the company's stock valued at $481,000 after acquiring an additional 15 shares during the last quarter. SteelPeak Wealth LLC raised its stake in shares of McKesson by 0.5% during the first quarter. SteelPeak Wealth LLC now owns 2,771 shares of the company's stock valued at $1,867,000 after acquiring an additional 15 shares during the last quarter. Finally, Keystone Financial Services boosted its holdings in McKesson by 1.2% in the first quarter. Keystone Financial Services now owns 1,404 shares of the company's stock valued at $945,000 after acquiring an additional 17 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

McKesson Trading Up 0.8%

Shares of McKesson stock opened at $763.89 on Friday. The business's fifty day simple moving average is $707.48 and its 200 day simple moving average is $706.39. The firm has a market capitalization of $95.01 billion, a P/E ratio of 30.46, a price-to-earnings-growth ratio of 1.38 and a beta of 0.52. McKesson Corporation has a 12 month low of $492.39 and a 12 month high of $776.14.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 EPS for the quarter, missing analysts' consensus estimates of $8.33 by ($0.07). McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The business had revenue of $97.83 billion for the quarter, compared to the consensus estimate of $95.93 billion. During the same quarter last year, the business posted $7.88 earnings per share. The business's revenue was up 23.4% compared to the same quarter last year. Analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd were given a $0.82 dividend. This is an increase from McKesson's previous quarterly dividend of $0.71. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, September 2nd. McKesson's dividend payout ratio (DPR) is 13.08%.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 11,930 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $705.63, for a total value of $8,418,165.90. Following the sale, the chief executive officer directly owned 4,012 shares in the company, valued at approximately $2,830,987.56. The trade was a 74.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total value of $218,347.43. Following the transaction, the chief accounting officer directly owned 657 shares of the company's stock, valued at $436,031.19. The trade was a 33.37% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 24,189 shares of company stock worth $16,722,190 over the last 90 days. 0.08% of the stock is currently owned by company insiders.

Analyst Ratings Changes

MCK has been the subject of several recent analyst reports. Leerink Partners increased their price objective on shares of McKesson from $785.00 to $850.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 24th. Evercore ISI increased their target price on shares of McKesson from $800.00 to $825.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 24th. Weiss Ratings restated a "buy (b)" rating on shares of McKesson in a report on Wednesday. Cowen restated a "buy" rating on shares of McKesson in a report on Wednesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of McKesson from $775.00 to $856.00 and gave the stock a "buy" rating in a report on Wednesday, September 24th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $829.08.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.